A randomized, multicenter, double-blind, parallel group study to compare the effects of bifeprunox and quetiapine on weight changes in stable schizophrenic patients.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Bifeprunox; Quetiapine
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Abbott Healthcare Products
- 20 Apr 2010 Actual patient number (83) added as reported by ClinicalTrials.gov.
- 29 Jan 2008 Status change from recruiting to suspended.
- 24 Nov 2006 New trial record.